Press Releases
In an effort to assist members of the press with planning coverage, the AAAAI makes its press releases available in advance of the 2024 Annual Meeting. Direct all questions to Candace Archie, at (414) 272-6071 or carchie@aaaai.org.
February 5: Acid-Suppressive Medication and Antimicrobial Use in Infancy Associated with Food Allergy and Anaphylaxis
February 5: Baked Milk Oral Immunotherapy Found to be Effective Treatment for Cow’s Milk Allergy
February 5: Early-Life Daycare Attendance Potentially Linked to Lower Risk of Asthma and Allergic Diseases
February 5: Early-Life Skin Microbiome and Metabolome Signatures Could Predict Atopic Dermatitis in Infants
February 5: Study Shows Nasal Powder Epinephrine Provides Superior Stability to EpiPens
February 5: Home Reintroduction of FPIES Food Triggers May Be Safe and Effective for Children
February 5: Non-Lesional Filaggrin Expression is Predictive of Asthma Development in Children with Atopic Dermatitis
February 5: Ozone and PM2.5 Exposure is Associated with Nasal Key Driver Gene Expression in People with Asthma
February 5: The Development of Allergic Disease Not Associated with Prenatal PM2.5 Air Pollution Exposure
February 5: Rebamipide May Combat Low-Grade Inflammation in Post-COVID-19 Syndrome Patients
February 5: PH Labelling of Skin Cleansers Can Lead to Better Options for People with Atopic Dermatitis
February 5: Most Effective Atopic Dermatitis Treatments May Also Be Most Harmful